ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

HIK Hikma Pharmaceuticals Plc

2,012.00
18.00 (0.90%)
13 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hikma Pharmaceuticals Plc LSE:HIK London Ordinary Share GB00B0LCW083 ORD SHS 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  18.00 0.90% 2,012.00 2,000.00 2,004.00 2,006.00 1,969.00 1,991.00 306,734 16:35:04
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 2.88B 192M 0.8685 23.05 4.43B
Hikma Pharmaceuticals Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker HIK. The last closing price for Hikma Pharmaceuticals was 1,994p. Over the last year, Hikma Pharmaceuticals shares have traded in a share price range of 1,711.00p to 2,222.00p.

Hikma Pharmaceuticals currently has 221,081,676 shares in issue. The market capitalisation of Hikma Pharmaceuticals is £4.43 billion. Hikma Pharmaceuticals has a price to earnings ratio (PE ratio) of 23.05.

Hikma Pharmaceuticals Share Discussion Threads

Showing 1326 to 1350 of 1875 messages
Chat Pages: Latest  63  62  61  60  59  58  57  56  55  54  53  52  Older
DateSubjectAuthorDiscuss
11/8/2021
22:24
No. They want vectors for its inhaler knowledge. This is why Hikma have the tie up
robertball
11/8/2021
19:15
Surely the loser for Vectura Pharma will look at Hikma, forecast p.e 16 at 2500p for a healthcare company is cheap.
montyhedge
09/8/2021
12:14
Completely oversold on Friday on record profits and increase dividends.Still everyone to their own on what they want.GSK shareprice below what it was 25 years ago, at least this doubles every 4 years.
montyhedge
09/8/2021
12:02
Hardly but shifts focus to the sector
robertball
09/8/2021
10:53
Bidding war for Vectura Pharma, perhaps the loser will turn attention toHikma.
montyhedge
06/8/2021
19:55
Market expects more. I'm off to the pub for some live music.
robertball
06/8/2021
19:41
monty your number much better - I just did the calculation again and got p/e 16.
Don't know what happened! I'm staying in. cheers

bigbertie
06/8/2021
18:27
Let's hope the Vectura Pharma bid fails, then they will come after Hikma after seeing these superb and growing profits.You never know.
montyhedge
06/8/2021
18:18
I have calculations of 220c full year eps, which converted roughly 160p Sterling at 2500p p.e 15.6Seems good value, record profits, dividend up. I don't know what investors were looking for.
montyhedge
06/8/2021
14:35
Share price reaction looks odd. If they continue this performance in 2H they are on a p/e of about 21 [at 2500p] for the year [my calculation] which looks fine.

I must read the results again. Meanwhile I'm holding - good luck all.

bigbertie
06/8/2021
12:45
We're going into liquidation - the chart looks like Beachy Head.
Suet

suetballs
06/8/2021
11:05
Good grief, odd reaction
scepticalinvestor
06/8/2021
10:37
Churlish market reaction - that's happened with a few stocks in last few weeks; expectations have got ahead of themselves, which quite often leads to a bit of market softness. But it is August.
18bt
06/8/2021
10:23
Record profits, not enough, lol.
montyhedge
06/8/2021
08:55
Indeed. Oh well
robertball
06/8/2021
08:29
Told you market always want more.
montyhedge
06/8/2021
08:17
If 2600 holds I think it'll get another leg up.
robertball
06/8/2021
08:14
I think on course for full year eps around 220c, so around 2600p p.e 16, in Sterling term, not high for a growing company. The holy grail of investing growing company profits and growing dividends.That will do me.
montyhedge
06/8/2021
07:55
Yup, happy with that. Capex seems less than market was expecting, so cashflow should be strong by YE
18bt
06/8/2021
07:52
On track and guidance marginally up.
robertball
06/8/2021
07:05
Looks a very strong performance, dividend up 13%.
montyhedge
05/8/2021
16:48
Thanks. I've held these for a while. Expecting dividend hike
robertball
05/8/2021
16:16
Good luck for tomorrow, I think the big winner only got approval April by FDA is KLOXXADOTM I think going to be a big winner for Hikma.
montyhedge
05/8/2021
14:07
Given rise over past month I won't worry. As always keep a -15% trailing stop loss.The drop could be profit taking. I haven't seen any disclosable share buys / sells.
robertball
05/8/2021
11:25
Robert
Does seem strange shareprice falls couple of days before figures. Does someone know something we don't. Lets see what the figures are, has long has in line with analysts forecasts should be ok.

montyhedge
Chat Pages: Latest  63  62  61  60  59  58  57  56  55  54  53  52  Older

Your Recent History

Delayed Upgrade Clock